Clobazam

Overview

Clobazam is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL70418).

API suppliers (9)

Suppliers of Clobazam evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• FIS FABBRICA ITALIANA SINTETICI SPAItaly1 active DMF GMP on record
• EUROAPI GERMANY GMBHGermany1 active DMF GMP on record
• CAMBREX PROFARMACO MILANO SRLItaly1 active DMF GMP on record
• Piramal Pharma LimitedIndia1 active DMF GMP on record
• HONOUR LAB LTDIndia1 active DMF GMP on record
• RAKS PHARMA PVT LTDIndia1 active DMF
• MSN LIFE SCIENCES PRIVATE LIMITEDIndia1 active DMF GMP on record
• Micro Labs Usa1 active DMF
• CENTAUR PHARMACEUTICALS PRIVATE LTD1 active DMF GMP on record

Patent & exclusivity (US)

Per the FDA Orange Book (34 approved US products), the latest listed US patent on Clobazam expires 31 Jan 2040. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

7-chloro-1-methyl-5-phenyl-1,5-benzodiazepine-2,4-dione

Canonical SMILES

CN1C(=O)CC(=O)N(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3

InChIKey

CXOXHMZGEKVPMT-UHFFFAOYSA-N